Literature DB >> 31090592

In Vivo Confocal Microscopy Automated Morphometric Analysis of Corneal Subbasal Nerve Plexus in Patients With Dry Eye Treated With Different Sources of Homologous Serum Eye Drops.

Giuseppe Giannaccare1, Marco Pellegrini1, Federico Bernabei1, Fabiana Moscardelli1, Marina Buzzi2, Piera Versura1, Emilio C Campos1.   

Abstract

PURPOSE: To investigate the comparative effect of allogeneic peripheral blood serum (allo-PBS) and cord blood serum (CBS) eye drops on the status of the corneal subbasal nerve plexus in patients with dry eye disease by using an automated analysis system of in vivo confocal microscopy images.
METHODS: This prospective, randomized, double-blind study included 30 patients with severe dry eye disease assigned to receive allo-PBS (group 1) or CBS (group 2) eye drops 8 times a day for 30 days. The following in vivo confocal microscopy parameters were calculated with ACCMetrics before (visit 1 [V1]) and after treatment (visit 2 [V2]): corneal nerve fiber density, corneal nerve branch density, corneal nerve fiber length, corneal nerve total branch density, corneal nerve fiber area, corneal nerve fiber width, and corneal nerve fractal dimension (CNFrD).
RESULTS: In overall patients, the values of corneal nerve fiber density, corneal nerve fiber length, and CNFrD significantly increased, whereas the value of corneal nerve fiber width significantly decreased at V2 compared with V1 (respectively, 20.4 ± 7.9 vs. 17.4 ± 10.1 n/mm; 13.5 ± 4.0 vs. 12.0 ± 5.1 mm/mm; 1.466 ± 0.046 vs. 1.475 ± 0.033; and 0.022 ± 0.002 vs. 0.023 ± 0.002; all P < 0.05). In the subanalysis according to the treatment type, the increase of CNFrD value from V1 to V2 was higher in group 2 compared with group 1 (respectively, from 1.455 ± 0.041 to 1.471 ± 0.030 and from 1.479 ± 0.050 to 1.481 ± 0.035; P = 0.030).
CONCLUSIONS: Overall, both treatments significantly improved corneal subbasal nerve plexus parameters, and in particular, nerve density, length, width, and fractal dimension. Treatment with CBS eye drops was associated with a higher increase of CNFrD compared with allo-PBS.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31090592     DOI: 10.1097/ICO.0000000000002005

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

Review 1.  Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus.

Authors:  Federico Bernabei; Matilde Roda; Marina Buzzi; Marco Pellegrini; Giuseppe Giannaccare; Piera Versura
Journal:  J Clin Med       Date:  2019-09-17       Impact factor: 4.241

2.  High Molecular Weight Hyaluronan Promotes Corneal Nerve Growth in Severe Dry Eyes.

Authors:  Gysbert-Botho van Setten; Oliver Stachs; Bénédicte Dupas; Semra Akkaya Turhan; Berthold Seitz; Herbert Reitsamer; Karsten Winter; Jutta Horwath-Winter; Rudolf F Guthoff; Wolfgang G K Müller-Lierheim
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

Review 3.  New Perspectives in the Pathophysiology and Treatment of Pain in Patients with Dry Eye Disease.

Authors:  Giuseppe Giannaccare; Carla Ghelardini; Alessandra Mancini; Vincenzo Scorcia; Lorenzo Di Cesare Mannelli
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

4.  Advances in Imaging of Subbasal Corneal Nerves With Micro-Optical Coherence Tomography.

Authors:  Merle S Schenk; Andreas Wartak; Verena Buehler; Jie Zhao; Guillermo J Tearney; Reginald Birngruber; Stefan Kassumeh
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

5.  Impact of blood source and component manufacturing on neurotrophin content and in vitro cell wound healing.

Authors:  Sabrina Valente; Nico Curti; Enrico Giampieri; Vanda Randi; Chiara Donadei; Marina Buzzi; Piera Versura
Journal:  Blood Transfus       Date:  2021-08-03       Impact factor: 5.752

Review 6.  The Role of Nutrition and Nutritional Supplements in Ocular Surface Diseases.

Authors:  Marco Pellegrini; Carlotta Senni; Federico Bernabei; Arrigo F G Cicero; Aldo Vagge; Antonio Maestri; Vincenzo Scorcia; Giuseppe Giannaccare
Journal:  Nutrients       Date:  2020-03-30       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.